Bireshwar Dasgupta

Person

East Hampton, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 11,713,316
- Issue date Aug 1, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyridopyrimidinonyl compounds useful as T cell activators
- Patent number 11,584,747
- Issue date Feb 21, 2023
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isofuranone compounds useful as HPK1 inhibitors
- Patent number 11,166,959
- Issue date Nov 9, 2021
- Bristol-Myers Squibb Company
- Erika M. V. Araujo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,954,238
- Issue date Mar 23, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,669,272
- Issue date Jun 2, 2020
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic kinase inhibitors
- Patent number 10,035,777
- Issue date Jul 31, 2018
- Bristol-Myers Squibb Company
- Carolyn Diane Dzierba
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline-based kinase inhibitors
- Patent number 9,932,320
- Issue date Apr 3, 2018
- Bristol-Myers Squibb Company
- Richard A. Hartz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolotriazine kinase inhibitors
- Patent number 9,737,542
- Issue date Aug 22, 2017
- Bristol-Myers Squibb Company
- Carolyn Diane Dzierba
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives a...
- Patent number 9,598,423
- Issue date Mar 21, 2017
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors
- Patent number 9,273,058
- Issue date Mar 1, 2016
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolyl derivatives as corticotropin releasing factor inhibitors
- Patent number 7,238,699
- Issue date Jul 3, 2007
- Bristol-Myers Squibb Company
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolyl derivatives as corticotropin releasing factor inhibitors
- Patent number 7,211,669
- Issue date May 1, 2007
- Bristol-Myers Squibb Company
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives
- Patent number 6,939,968
- Issue date Sep 6, 2005
- Bristol-Myers Squibb Company
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolyl derivatives as corticotropin releasing factor inhibitors
- Patent number 6,888,004
- Issue date May 3, 2005
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neurotrophic difluoroamide agents
- Patent number 6,239,146
- Issue date May 29, 2001
- Bristol-Myers Squibb Company
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neurotrophic difluoroamide agents
- Patent number 6,096,762
- Issue date Aug 1, 2000
- Bristol-Myers Squibb Company
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20240400563
- Publication date Dec 5, 2024
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF A T CELL THERAPY AND A DGK INHIBITOR
- Publication number 20240108654
- Publication date Apr 4, 2024
- Juno Therapeutics, Inc.
- David G. KUGLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230151007
- Publication date May 18, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS
- Publication number 20230089255
- Publication date Mar 23, 2023
- Bristol-Myers Squibb Company
- Susan WEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20220324859
- Publication date Oct 13, 2022
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210061802
- Publication date Mar 4, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOFURANONE COMPOUNDS USEFUL AS HPK1 INHIBITORS
- Publication number 20200390776
- Publication date Dec 17, 2020
- Bristol-Myers Squibb Company
- Erika M.V. Araujo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20200109140
- Publication date Apr 9, 2020
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC KINASE INHIBITORS
- Publication number 20170260145
- Publication date Sep 14, 2017
- Bristol-Myers Squibb Company
- Carolyn Diane Dzierba
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINAZOLINE-BASED KINASE INHIBITORS
- Publication number 20170239249
- Publication date Aug 24, 2017
- Bristol-Myers Squibb Company
- Richard A. HARTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Quinoline-Based Kinase Inhibitors
- Publication number 20160332985
- Publication date Nov 17, 2016
- Bristol-Meyers Squibb Company
- Richard A. Hartz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES A...
- Publication number 20160311824
- Publication date Oct 27, 2016
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLOTRIAZINE KINASE INHIBITORS
- Publication number 20160243125
- Publication date Aug 25, 2016
- Carolyn Diane Dzierba
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIB...
- Publication number 20160122358
- Publication date May 5, 2016
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIB...
- Publication number 20150133428
- Publication date May 14, 2015
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazolyl derivatives as corticotropin releasing factor inhibitors
- Publication number 20040254382
- Publication date Dec 16, 2004
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazolyl derivatives as corticotropin releasing factor inhibitors
- Publication number 20040225001
- Publication date Nov 11, 2004
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives
- Publication number 20040147749
- Publication date Jul 29, 2004
- Vivekananda M. Vrudhula
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazolyl derivatives as corticotropin releasing factor inhibitors
- Publication number 20020183375
- Publication date Dec 5, 2002
- Gene M. Dubowchik
- C07 - ORGANIC CHEMISTRY

Bireshwar Dasgupta

Person

Patents Grantslast 30 patents

Substituted naphthyridinone compounds useful as T cell activators

Substituted pyridopyrimidinonyl compounds useful as T cell activators

Isofuranone compounds useful as HPK1 inhibitors

Substituted naphthyridinone compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

Heterocyclic kinase inhibitors

Quinoline-based kinase inhibitors

Pyrrolotriazine kinase inhibitors

Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives a...

Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors

Imidazolyl derivatives as corticotropin releasing factor inhibitors

Imidazolyl derivatives as corticotropin releasing factor inhibitors

Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives

Imidazolyl derivatives as corticotropin releasing factor inhibitors

Neurotrophic difluoroamide agents

Neurotrophic difluoroamide agents

Patents Applicationslast 30 patents

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

COMBINATION OF A T CELL THERAPY AND A DGK INHIBITOR

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

ISOFURANONE COMPOUNDS USEFUL AS HPK1 INHIBITORS

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

HETEROCYCLIC KINASE INHIBITORS

QUINAZOLINE-BASED KINASE INHIBITORS

Quinoline-Based Kinase Inhibitors

SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES A...

PYRROLOTRIAZINE KINASE INHIBITORS

NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIB...

NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIB...

Imidazolyl derivatives as corticotropin releasing factor inhibitors

Imidazolyl derivatives as corticotropin releasing factor inhibitors

Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives

Imidazolyl derivatives as corticotropin releasing factor inhibitors